This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Smartwatches gather vast amounts of data about our physiology. Now their technology is being harnessed like never before.

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

Binzer died at his home in Los Angeles on June 24 from an accidental drug overdose, according to his manager ... that he was ...

Takes you closer to the games, movies and TV you love Issues delivered straight to your door or device ...

BioSpace has been compiling a list of the most innovative and exciting biotechs for a decade. Here we take a look back at ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

Reid Health’s Rock Steady Boxing program is receiving $15,000 from the Parkinson’s Foundation. One of 40 community grant ...

Brain Trust How UAB changed the game in neuroscience research recruitment Story by Matt Windsor | Illustrations by Jody ...

That headline comes courtesy of a recent study out of Stanford Medicine, published in the journal Nature ... (The Stanford ...

A new study shows that a common glaucoma drug cleared tau build-up and reduced signs of neurodegenerative disease in zebrafish and mice.